OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
Xin Liu, Shuxin Zhong, Kangjie Qiu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Xin Liu, Shuxin Zhong, Kangjie Qiu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Showing 23 citing articles:
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
Chengwu Zeng, Dingrui Nie, Xianfeng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Chengwu Zeng, Dingrui Nie, Xianfeng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies
Hanyun Zhang, Chunjie Sun, Qi Sun, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Hanyun Zhang, Chunjie Sun, Qi Sun, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
ALKBH3-mediated m1A demethylation promotes the malignant progression of acute myeloid leukemia by regulating ferroptosis through the upregulation of ATF4 expression
Xin Liu, Xinghua Pan
Hematology (2025) Vol. 30, Iss. 1
Open Access
Xin Liu, Xinghua Pan
Hematology (2025) Vol. 30, Iss. 1
Open Access
ieGENES: A machine learning method for selecting differentially expressed genes in cancer studies
Xiao-Lei Xia, Shang‐Ming Zhou, Yunguang Liu, et al.
Journal of Biomedical Informatics (2025), pp. 104803-104803
Open Access
Xiao-Lei Xia, Shang‐Ming Zhou, Yunguang Liu, et al.
Journal of Biomedical Informatics (2025), pp. 104803-104803
Open Access
SR-B1 deficiency suppresses progression in acute myeloid leukemia via ferroptosis and reverses resistance to venetoclax
Junfeng Shi, Yifeng Cheng, Lixue Wang, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Junfeng Shi, Yifeng Cheng, Lixue Wang, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Synergistic Effects of BET Inhibitors and Ferroptosis Inducers via Targeted Inhibition of the BRD4/c-Myc/NRF2 Pathway in AML
Mengjun Zhong, Shuxin Zhong, Kangjie Qiu, et al.
European Journal of Pharmacology (2025), pp. 177652-177652
Closed Access
Mengjun Zhong, Shuxin Zhong, Kangjie Qiu, et al.
European Journal of Pharmacology (2025), pp. 177652-177652
Closed Access
Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export
Guangyao Shan, Yunyi Bian, Shencheng Ren, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Guangyao Shan, Yunyi Bian, Shencheng Ren, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Targeting USP10–FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitors
Kangjie Qiu, Xianfeng Wang, Zhen Liu, et al.
Cell investigation. (2025) Vol. 1, Iss. 2, pp. 100017-100017
Open Access
Kangjie Qiu, Xianfeng Wang, Zhen Liu, et al.
Cell investigation. (2025) Vol. 1, Iss. 2, pp. 100017-100017
Open Access
miR-4478 Promotes Ferroptosis of Nucleus Pulposus Cells through Targeting SLC7A11 to Induce IVDD
De-jun GONG, Long Jia, Yuhang Wang, et al.
Folia Biologica (2025) Vol. 71, Iss. 1, pp. 29-43
Closed Access
De-jun GONG, Long Jia, Yuhang Wang, et al.
Folia Biologica (2025) Vol. 71, Iss. 1, pp. 29-43
Closed Access
Synergistic suppression of ovarian cancer by combining NRF2 and GPX4 inhibitors: in vitro and in vivo evidence
Ning Li, Xingmei Jiang, Qing‐Yu Zhang, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Ning Li, Xingmei Jiang, Qing‐Yu Zhang, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options
Yaonan Hong, Qi Liu, Chuanao Xin, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 3837-3853
Open Access | Times Cited: 2
Yaonan Hong, Qi Liu, Chuanao Xin, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 3837-3853
Open Access | Times Cited: 2
Ferroptosis in hepatocellular carcinoma: Mechanisms and therapeutic implications
Shanjie Tu, Yisheng Zou, Meiqi Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117769-117769
Closed Access | Times Cited: 2
Shanjie Tu, Yisheng Zou, Meiqi Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117769-117769
Closed Access | Times Cited: 2
CASP1 is a target for combination therapy in pancreatic cancer
Xianfeng Wang, Zheng Chen, Dingrui Nie, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176175-176175
Closed Access | Times Cited: 6
Xianfeng Wang, Zheng Chen, Dingrui Nie, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176175-176175
Closed Access | Times Cited: 6
Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy
Xiao Tang, Yujie Niu, Jinli Jian, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104203-104203
Closed Access | Times Cited: 5
Xiao Tang, Yujie Niu, Jinli Jian, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104203-104203
Closed Access | Times Cited: 5
Brain‐Decellularized ECM‐Based 3D Myeloid Sarcoma Platform: Mimicking Adaptive Phenotypic Alterations in the Brain
Heejeong Yoon, Joo H. Kang, Seung Woo Cho, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 13
Closed Access | Times Cited: 1
Heejeong Yoon, Joo H. Kang, Seung Woo Cho, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 13
Closed Access | Times Cited: 1
BET Inhibitor JQ1 Selectively Reduce Tregs by Upregulating STAT3 and Suppressing PD‐1 Expression in Patients with Multiple Myeloma
Youxue Huang, Mengjun Zhong, Rili Gao, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 1
Youxue Huang, Mengjun Zhong, Rili Gao, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 1
TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
The interplay between cell death and senescence in cancer
Kouhei Shimizu, Hiroyuki Inuzuka, Fuminori Tokunaga
Seminars in Cancer Biology (2024) Vol. 108, pp. 1-16
Open Access | Times Cited: 1
Kouhei Shimizu, Hiroyuki Inuzuka, Fuminori Tokunaga
Seminars in Cancer Biology (2024) Vol. 108, pp. 1-16
Open Access | Times Cited: 1
Targeting GPX4 degradation through disulfiram: A novel mechanism for ferroptosis induction in leukemia cells
Caixia Wang, Shunqing Wang
Cell investigation. (2024) Vol. 1, Iss. 1, pp. 100006-100006
Open Access | Times Cited: 1
Caixia Wang, Shunqing Wang
Cell investigation. (2024) Vol. 1, Iss. 1, pp. 100006-100006
Open Access | Times Cited: 1
A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia
Feima Wu, Xu Guosheng, Guangchao Li, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Feima Wu, Xu Guosheng, Guangchao Li, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia
Daniel Zechariah Paul Jebanesan, Raveen Stephen Stallon Illangeswaran, Bharathi M. Rajamani, et al.
Annals of Hematology (2024) Vol. 103, Iss. 6, pp. 1919-1929
Closed Access
Daniel Zechariah Paul Jebanesan, Raveen Stephen Stallon Illangeswaran, Bharathi M. Rajamani, et al.
Annals of Hematology (2024) Vol. 103, Iss. 6, pp. 1919-1929
Closed Access
Enhancement of Breast Cancer Chemotherapy and Radiotherapy Responses by Modulation of Ferroptosis
Alaa A.M. Al-Zufairi
(2024)
Open Access
Alaa A.M. Al-Zufairi
(2024)
Open Access
Potential of NRF2 Inhibitors—Retinoic Acid, K67, and ML-385—In Overcoming Doxorubicin Resistance in Promyelocytic Leukemia Cells
Michał Juszczak, Paulina Tokarz, Katarzyna Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10257-10257
Open Access
Michał Juszczak, Paulina Tokarz, Katarzyna Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10257-10257
Open Access
